Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 26, 2023; 11(24): 5678-5691
Published online Aug 26, 2023. doi: 10.12998/wjcc.v11.i24.5678
Table 8 Efficacy analysis of each indicator in predicting primary hypertension
Indicator
hs-CRP
TM
Hct
ESR
CD62P
PLT
APTT
PT
TT
FIB
hs-CRP-0.792a0.237 (0.003)0.782a0.753a-0.296a-0.794a-0.652a-0.631a0.802a
TM0.792a-0.300a0.818a0.813a-0.329a-0.856a-0.734a-0.682a0.846a
Hct0.237 (0.003)0.300a-0.317a0.279a-0.113 (0.153)-0.295a-0.201 (0.011)-0.279a0.318a
ESR0.782a0.818a0.317a-0.788a-0.267 (0.001)-0.821a-0.665a-0.626a0.830a
CD62P0.753a0.813a0.279a0.788a--0.246 (0.002)-0.850a-0.707a-0.668a0.814a
PLT-0.296a-0.329a-0.113 (0.153)-0.267 (0.001)-0.246 (0.002)-0.331a0.214 (0.007)0.223 (0.005)-0.272 (0.001)
APTT0.794a0.856a0.295a0.821a0.850a-0.331-0.677a0.681a-0.843a
PT0.652a0.734a0.201 (0.011)0.665a0.707a-0.214 (0.007)0.677a-0.534a-0.739a
TT0.631a0.682a0.279a0.626a0.668a-0.223 (0.005)0.681a0.534a--0.674a
FIB0.802a0.846a0.318a0.830a0.814a-0.272 (0.001)-0.843a-0.739a-0.674a-